Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about clarification

01 Mar 2019 Evaluate

Aurobindo Pharma has informed about clarification on news item appeared in business standard on February 27, 2019 titled ‘Lacunae in Aurobindo Pharma's Medak facility in Andhra, says FDA report’ and in Financial Express on February 28, 2019 titled ‘Lacunae in Aurobindo Pharma's facility: FDA report’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..